1 / 4

UK COVID-19 Diagnostics Market Growth, Size, Share, Industry Report and Forecast to 2026

UK COVID-19 diagnostics market is estimated to see a decline in CAGR of 30.9% during the forecast period. UK is among the top five European countries in terms of the most prevalent COVID-19 incidences. As a result, a rapid surge in the demand for COVID-19 diagnostic tools has been reported in the country.

Download Presentation

UK COVID-19 Diagnostics Market Growth, Size, Share, Industry Report and Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research UK COVID-19 Diagnostics Market Share, Trends, Size, Research and Forecast 2020-2026 Request https://www.omrglobal.com/request-sample/uk-covid-19-diagnostics-market ------------------------------------------------------------------------------------ a free sample of our report on UK COVID-19 Diagnostics Market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780304040

  2. UK COVID-19 Diagnostics industry will see the considerable decline of 30.9% during the forecast period. The government, research institutes, and healthcare firms are collaborating for the development of COVID-19 diagnosis solutions. UK Biobank has recruited 20,000 volunteers, a combination of UK Biobank participants, their adult children, and grandchildren, to produce results that are representative of the UK population. They are providing a finger-prick sample of blood using a kit sent to their home every month for at least 6 months. Antibodies to SARS-CoV-2 in these samples are being measured in a central laboratory at Oxford University which provides evidence of the previous infection with the virus. These first results provide a snapshot for May and June of past SARS-CoV-2 infection, revealing that overall, in the study, 7.1% of the participants had been infected previously. The rate of the previous infection was higher among people of Black (11.3%) and South Asian (9.0%) ethnicity than among those of White ethnicity (6.9%). A full Report of UK COVID-19 Diagnostics Market Available at: https://www.omrglobal.com/industry- reports/uk-covid-19-diagnostics-market On April 07, 2020, as part of the announcement by the UK government to leverage COVID-19 testing, (GSK), AstraZeneca, and the University of Cambridge have entered into a joint partnership to take action for supporting this national effort. Under the collaboration, a new testing laboratory will be established by AstraZeneca, GSK, and the University of Cambridge. The facility will be utilized for high throughput screening for testing of COVID-19 and to explore the utilization of alternative chemical reagents for test kits to support overcome current supply shortages. Along with this new testing facility, AstraZeneca and GSK are working together to offer support for process optimization to the UK national testing centers in Milton Keynes, Alderley Park and Glasgow for COVID-19, offering expertise in robotics and automation to support the national testing system to continuously accelerate capacity over the coming weeks. On 8th April, Novacyt declared that it has collaborated with AstraZeneca, GlaxoSmithKline, and the University of Cambridge to support this national effort. Under the collaboration, Novacyt will ensure an efficient workflow process in the COVID-19 testing facility, as well as deliver its COVID-19 test to produce results data. Novacyt’s COVID-19 PCR test has been developed by Primerdesign, its molecular diagnostics division, based in Southampton, UK. This collaboration has actively supported to meet the testing needs of the country. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/uk-covid-19-diagnostics-market Key questions addressed by the report •What is the market growth rate during the forecast period? •Which segment dominates the market in base year? •Which segment will project fastest growth in the market during the forecast period? •How COVID-19 will impact the market growth in 2020 and coming years?

  3. •Who is the leader in the market? •How players are addressing challenges to sustain growth? •Where is the investment opportunity? UK COVID-19 Diagnostics Market – Segmentation By Type •Instruments •Reagents & Kits •Laboratory Testing Services By Technology Type •PCR Test •Antigen Test •Serology Test •Rapid/ PoC Test By Sample Type •Oropharyngeal & Nasopharyngeal Swabs •Blood •Urine •Saliva •Others (Sperm) By End-Users •Laboratories •Hospitals •Diagnostic Centers & Clinics •Research Institutes Company Profiles •Abingdon Health Ltd. •AstraZeneca plc •Babylon Health •DnaNudge Ltd. •GlaxoSmithKline plc •Mologic Ltd.

  4. •Novacyt Group •Omega Diagnostics Group •Oxford Nanopore Technologies Ltd. •Surescreen Diagnostics Ltd. For More Customized Data, Request for Report Customization https://www.omrglobal.com/report- customization/uk-covid-19-diagnostics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related